skip to content

Centre For Cancer Genetic Epidemiology

 
  1. CIMBA+
  • CIMBA+ is planning to collect data, and later germline DNA, on pathogenic and likely pathogenic PALB2, ATM, CHEK2, RAD51D, BRIP1, TP53, CDH1, PTEN, MSH6, FANCM and STK11 female and male mutation carriers. 
  1. Genotyping (GWAS)

Next page: Data & Data Access